meropenem and Mycobacterium-Infections

meropenem has been researched along with Mycobacterium-Infections* in 1 studies

Reviews

1 review(s) available for meropenem and Mycobacterium-Infections

Article	Year
Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:7 Described here is the case of a patient with infective endocarditis in a prosthetic valve due to a Mycobacterium fortuitum-group organism. The patient was treated medically and had a favorable clinical response. This is only the second report of survival after Mycobacterium fortuitum-group endocarditis, and the first of survival without surgical intervention. The duration of treatment is not well defined for this patient, but life-long suppressive therapy will likely be required. Topics: Aged; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Meropenem; Mycobacterium fortuitum; Mycobacterium Infections; Prosthesis-Related Infections; Thienamycins	2002

Article

Year

Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:7

Described here is the case of a patient with infective endocarditis in a prosthetic valve due to a Mycobacterium fortuitum-group organism. The patient was treated medically and had a favorable clinical response. This is only the second report of survival after Mycobacterium fortuitum-group endocarditis, and the first of survival without surgical intervention. The duration of treatment is not well defined for this patient, but life-long suppressive therapy will likely be required.

Topics: Aged; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Meropenem; Mycobacterium fortuitum; Mycobacterium Infections; Prosthesis-Related Infections; Thienamycins

2002